State-of-the-art approach helps EPA identify chemical risks

April 12, 2007
The National Center for Computational Toxicology (NCCT) of the Office and Research and Development of the U.S. Environmental Protection Agency (EPA) announces the awarding of eight contracts for the generation of high-throughput screening (HTS) bioassay data to support the ToxCast™ program, an innovative approach for prioritization of chemicals for toxicological testing...

WASHINGTON, DC, April 11, 2007 --The National Center for Computational Toxicology (NCCT) of the Office and Research and Development of the U.S. Environmental Protection Agency (EPA) announces the awarding of eight contracts for the generation of high-throughput screening (HTS) bioassay data to support the ToxCast™ program, an innovative approach for prioritization of chemicals for toxicological testing.

Results from these contracts will provide, for the first time, a comprehensive and detailed overview of the potential impact of environmental chemicals upon key cellular activities.

The contracts range from characterizing the interactions of chemicals with proteins that regulate and maintain proper cell function, to measuring the response of whole cells, to studying chemical effects in a model organism, for up to 10,000 environmental chemicals. "The ToxCast Program will break new ground with this approach, and this cutting-edge research will help EPA make the most informed decisions to protect human health and the environment.

Using available technology in an innovative and across-the-board manner will not only save time and money, but provide better information to our decision makers about the hazards of chemicals" said Dr. George Gray, assistant administrator for the Office of Research and Development.

The ToxCast Program is a new tool that can provide data to help the Agency's regulatory programs prioritize chemicals for more rigorous testing.

Using state-of-the-art approaches developed in the pharmaceutical industry, EPA will soon have another pioneering, cost-efficient way to prioritize environmental chemicals for more thorough examination of their potential to harm people or the environment. These tests provide information on the potential impact of chemicals on biological pathways critical for the function of systems such as the heart, lungs, brain or reproductive organs quickly and in a more cost-efficient manner.

Armed with this science-based information, EPA can prioritize chemicals for more detailed and expensive toxicological evaluations, including using the animal tests more efficiently. This five-year effort will be divided into three phases.

In the initial phase, as a proof-of-concept, ToxCast will examine more than 300 chemicals, in hundreds of different HTS bioassays, to create predictive signatures based on the known toxicity of the 300 chemicals.

Phase II will focus on the expansion and validation of ToxCast predictive signatures, generating data on over 1000 additional chemicals. In Phase III, ToxCast will be expanded to the thousands of environmental chemicals requiring prioritization, delivering an affordable, science-based system for categorizing chemicals. As the ToxCast database grows so will confidence in predicted toxicity and potential mechanisms of action useful in refining and reducing the use of animals in toxicity testing. Phase I results are anticipated by the summer of 2008, and to ensure transparency and collaboration, ToxCast data will be freely available at PubChem, a National Library of Medicine public database that stores information about the biological activities of small molecules.

The approach and the chosen assays will also be discussed at the upcoming International Science Forum on Computational Toxicology to be held at the EPA campus in North Carolina on May 21-23, 2007. ToxCast HTS contract awardees:
• ACEA Biosciences, Inc. (San Diego, Calif.)
• Attagene, Inc. (Morrisville, N.C.)
• BioSeek Inc. (Burlingame, Calif.)
• Cellumen, Inc. (Pittsburgh, Pa.)
• Expression Analysis, Inc. (Durham, N.C.)
• In Vitro ADMET Laboratories (IVAL), LLC. (Rockville, Md.)
• NovaScreen Biosciences Corp. (Hanover, Md.)
• Phylonix Pharmaceuticals, Inc. (Cambridge, Mass.)

---

Also see:
-- For more information on the ToxCast program, click here.
-- For a list of the ToxCast awards and more information about each project, click here.
-- National Center for Computational Toxicology
-- Chemical Prioritization Community of Practice
-- National Library of Medicine public database, PubChem
-- International Science Forum on Computational Toxicology
-- EPA's Office of Research and Development

# # #

Sponsored Recommendations

ArmorBlock 5000: Boost Automation Efficiency

April 25, 2024
Discover the transformative benefits of leveraging a scalable On-Machine I/O to improve flexibility, enhance reliability and streamline operations.

Rising Cyber Threats and the Impact on Risk and Resiliency Operations

April 25, 2024
The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

State of Smart Manufacturing Report Series

April 25, 2024
The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

SmartSights WIN-911 Alarm Notification Software Enables Faster Response

March 15, 2024
Alarm notification software enables faster response for customers, keeping production on track